Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTreatment OutcomeTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingCombined Modality TherapyCyclophosphamideHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityRecurrenceTransplantation, IsogeneicRetrospective StudiesBone Marrow DiseasesTime FactorsKidney TransplantationHematopoiesisImmunosuppressive AgentsMice, Inbred C57BLRadiation ChimeraFatal OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteSurvival AnalysisAcute DiseaseRemission InductionPrognosisFollow-Up StudiesHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidSurvival RateAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressionLymphocyte DepletionStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesDisease-Free SurvivalHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisCyclosporineBone DensityHematologic DiseasesHodgkin DiseaseProspective StudiesLymphocyte TransfusionNuclear FamilyCarmustineOrgan TransplantationPancytopeniaMethotrexateGraft vs Tumor EffectRisk FactorsCell DifferentiationLeukocyte CountGraft vs Leukemia EffectCytarabineCytomegalovirus InfectionsBone ResorptionPostoperative ComplicationsSpleenGranulocyte Colony-Stimulating FactorMelphalanMice, Inbred BALB CEtoposideFlow CytometryLymphomaMultiple MyelomaVincristineCells, CulturedAntigens, CD34